United Therapeutics buy Royal Bank of Canada
Start price
26.09.25
/
50%
€364.40
Target price
26.09.26
€487.63
Performance (%)
8.53%
Price
19:13
€395.50
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 8.53%. This prediction currently runs until 26.09.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | -1.230% | -1.230% |
| iShares Core DAX® | -1.673% | 2.237% |
| iShares Nasdaq 100 | -1.346% | 0.290% |
| iShares Nikkei 225® | -1.529% | 5.863% |
| iShares S&P 500 | -1.702% | 0.697% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics (NASDAQ:UTHR) is now covered by analysts at Royal Bank Of Canada. They set an "outperform" rating and a $569.00 price target on the stock.
Ratings data for UTHR provided by MarketBeat